Biophytis SA (0D1W) Ratios
Biophytis SA Ratios
GB:0D1W's free cash flow for Q4 2024 was $-2.68K. For the 2024 fiscal year, GB:0D1W's free cash flow was increased by $9.00 and operating cash flow was $-2.65M. See a summary of the company’s cash flow.
| Ratios | Jun 25 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.25 | 0.72 | 0.96 | 1.38 | 1.05 |
| Quick Ratio | 0.25 | 0.72 | 0.88 | 1.41 | 1.05 |
| Cash Ratio | 0.00 | 0.45 | 0.57 | 1.05 | 0.26 |
| Solvency Ratio | -0.61 | -1.04 | -0.99 | -1.01 | -1.24 |
| Operating Cash Flow Ratio | -0.55 | -1.04 | -0.98 | -1.04 | -0.43 |
| Short-Term Operating Cash Flow Coverage | -0.96 | -2.59 | -1.86 | -2.01 | -0.75 |
| Net Current Asset Value | $ -12.68M | $ -7.00M | $ -5.32M | $ 809.00K | $ 3.63M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 1.43 | 0.69 | 0.66 | 0.48 | 0.33 |
| Debt-to-Equity Ratio | -1.02 | -2.14 | -7.76 | 3.01 | 3.96 |
| Debt-to-Capital Ratio | 56.56 | 1.87 | 1.15 | 0.75 | 0.80 |
| Long-Term Debt-to-Capital Ratio | -0.07 | -4.17 | 1.82 | 0.48 | 0.44 |
| Financial Leverage Ratio | -0.71 | -3.10 | -11.70 | 6.21 | 11.84 |
| Debt Service Coverage Ratio | -0.83 | -1.97 | -1.87 | -1.77 | -0.59 |
| Interest Coverage Ratio | -9.75 | -11.46 | -14.57 | -6.05 | -3.19 |
| Debt to Market Cap | 4.92 | 2.92 | 1.81 | 0.29 | 0.28 |
| Interest Debt Per Share | 2.06 | 7.02 | 37.45 | 74.53 | 91.01 |
| Net Debt to EBITDA | -1.18 | -0.20 | -0.14 | 0.24 | -0.24 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 99.94% | 91.60% | 100.00% | 99.73% | 100.00% |
| EBT Per EBIT | 122.18% | 129.68% | 104.06% | 116.53% | 183.02% |
| Return on Assets (ROA) | -150.38% | -142.36% | -110.14% | -85.94% | -93.78% |
| Return on Equity (ROE) | 107.35% | 441.43% | 1288.77% | -534.07% | -1109.92% |
| Return on Capital Employed (ROCE) | 97.63% | 3539.01% | -881.85% | -199.34% | -325.06% |
| Return on Invested Capital (ROIC) | -2242.74% | -285.79% | -155.56% | -106.56% | -69.25% |
| Return on Tangible Assets | -241.88% | -182.62% | -125.26% | -93.01% | -103.99% |
| Earnings Yield | -526.51% | -615.04% | -304.65% | -53.36% | -46.80% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.07 | 0.15 | 0.07 | 0.04 | 0.04 |
| Inventory Turnover | 0.00 | 0.00 | 0.31 | -0.44 | 9.66 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -5242.28 | -2450.91 | -4046.67 | -9758.76 | -10371.21 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 1187.00 | -832.11 | 37.80 |
| Days of Payables Outstanding | 5242.28 | 2450.91 | 5233.68 | 8926.66 | 10409.02 |
| Operating Cycle | 0.00 | 0.00 | 1187.00 | -832.11 | 37.80 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.67 | -9.49 | -43.95 | -80.66 | -66.65 |
| Free Cash Flow Per Share | -1.67 | -9.65 | -44.28 | -81.83 | -68.09 |
| Dividend Paid and CapEx Coverage Ratio | -0.94 | -58.51 | -134.67 | -69.17 | -46.09 |
| Capital Expenditure Coverage Ratio | -0.94 | -58.51 | -134.67 | -69.17 | -46.09 |
| Operating Cash Flow Coverage Ratio | -0.88 | -1.56 | -1.30 | -1.36 | -1.08 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -438.44% | -472.97% | -240.65% | -41.34% | -18.48% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.19 | -0.16 | -0.33 | -1.87 | -2.14 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -0.20 | -0.72 | -4.23 | 10.01 | 23.72 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.23 | -0.21 | -0.42 | -2.42 | -5.41 |
| Price-to-Operating Cash Flow Ratio | -0.23 | -0.22 | -0.42 | -2.45 | -5.53 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.00 | 0.01 | 0.05 | 0.03 |
| Enterprise Value Multiple | -1.42 | -0.40 | -0.45 | -1.96 | -4.23 |
| Enterprise Value | 11.74M | 5.47M | 11.48M | 52.03M | 57.77M |
| EV to EBITDA | -1.42 | -0.40 | -0.45 | -1.96 | -4.23 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -1.36 | -0.42 | -0.60 | -2.16 | -5.73 |
| EV to Operating Cash Flow | -1.36 | -0.43 | -0.60 | -2.19 | -5.86 |
| Tangible Book Value Per Share | -2.37 | -4.81 | -10.57 | 9.99 | 28.10 |
| Shareholders’ Equity Per Share | -1.86 | -2.84 | -4.35 | 19.78 | 15.53 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.08 | 0.14 | -0.07 | 0.13 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -2.00 | -12.55 | -56.06 | -105.64 | -172.41 |
| Tax Burden | 1.00 | 0.92 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.22 | 1.30 | 0.93 | 1.17 | 1.83 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.83 | 0.76 | 0.78 | 0.76 | 0.58 |
Currency in EUR
